Avandia (TM) - From molecule to market for type 2 diabetes.

David Haigh

Research output: Contribution to journalArticle

Abstract

Type 2 diabetes is a disease fast approaching epidemic proportions throughout the world. From insulin sensitizers to PPARg agonists, the lecture will outline the successful medicinal chem. and biol. strategy underpinning the discovery and selection of Avandia, an innovative new medicine for this disease.
Original languageEnglish
Pages (from-to)MEDI-132-MEDI-132
Number of pages1
JournalAbstracts Of Papers Of The American Chemical Society
Volume223
Publication statusPublished - Apr 2002

Fingerprint Dive into the research topics of 'Avandia (TM) - From molecule to market for type 2 diabetes.'. Together they form a unique fingerprint.

  • Cite this